Package 0713-0877-30

{"route": ["ORAL"], "spl_id": "004953ba-fe11-03eb-e063-6394a90a638c", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0307130876308", "0307130874304", "0307130877305", "0307130878302", "0307130875301"], "unii": ["0J48LPH2TH", "864V2Q084H", "6M97XTV3HD"], "rxcui": ["999967", "999971", "999986", "999990", "999991", "999995", "999996", "1000000", "1000001", "1000005"], "spl_set_id": ["2f56d0bc-236b-41a0-9fc0-21cdfea8d890"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Cosette Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0713-0877-30)", "package_ndc": "0713-0877-30", "marketing_start_date": "20220901"}], "brand_name": "Tribenzor", "product_id": "0713-0877_004953ba-fe11-03eb-e063-6394a90a638c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0713-0877", "generic_name": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "labeler_name": "Cosette Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tribenzor", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "NDA200175", "marketing_category": "NDA", "marketing_start_date": "20220901", "listing_expiration_date": "20261231"}